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RGK Family G-Domain:GTP Analog Complex Structures and Nucleotide-
Binding Properties
Yehezkel Sasson.
Tel Aviv University, Tel-Aviv, Israel.
The RGK family of small G-proteins, including Rad, Gem, Rem1 and Rem2,
are inducibly expressed in various mammalian tissues and interact with
voltage-dependent calcium channels and Rho kinase. To test whether RGK pro-
teins undergo a nucleotide-induced conformational change, we determined the
crystallographic structures of G-domains from Rad and Rem2 bound to
GppNHp, a GTP analog, and compared them to their respective GDP bound
structures . Also, we characterized the nucleotide-binding properties and con-
formations for Gem, Rad, and several structure-based mutants using fluores-
cence spectroscopy. The results show that RGK G-proteins may not behave
as Ras-like canonical nucleotide-induced molecular switches. Further, the var-
ious RGK proteins have differing structures and nucleotide-binding properties,
which may have implications for their varied action on effectors. Ongoing
functional studies will be described.
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Fibrillin is a 350kDa calcium-binding glycoprotein that is vital for the forma-
tion of elastic and non-elastic fibres in connective tissue. It is secreted into
the extracellular matrix by fibroblasts and becomes incorporated into insolu-
ble microfibrils, which provide a scaffold for deposition of elastin. Fibrillin-1
(FBN1) also interacts with latent transforming growth factor-b binding pro-
teins and controls TGF-b bioavailability Mutations in fibrillin are associated
with several different connective tissue diseases, especially Marfan syndrome
(MFS). Fibrillin mutations may result in defective microfibrils, but also may
cause dysregulation of TGF-b activation and signalling. FBN1 consists of
repeating EGF (epidermal growth factor) and TB (transforming growth factor
b-binding protein) domains. The majority of EGF domains are paired, are sta-
bilised by multiple disulfides and contain a Ca2þ binding consensus sequence
(cbEGF), which confers structural rigidity to the fragment, producing a
rod-like conformation by structural and dynamic studies of tandem repeats
of cbEGF domains. TB domains exist uniquely in the microfibril protein
family, locating in extracellular matrix fibrils; the major function is involved
in extracellular matrix construction and storage of latent TGF-b. We have
examined the locations of over 600 mutations in fibrillin-1 that cause MFS,
then correlated and classified the mutations in terms of their structural and
functional consequences. We have shown that a large majority of missense
mutations alter cbEGF tandem repeat structural rigidity, by either altering
disulfide formation, Ca2þ binding or domain interactions. In other cases, stor-
age of latent TGF-b is predicted to be altered due to TB domain structural
perturbations.
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from Clostridium Histolyticum Collagenase: Insight into the Role of the
PKD in Collagenase
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Clostridium histolyticum secretes multidomain collagenases ColG and ColH to
cause extensive tissue destruction in the presence of calcium. ColG collage-
nase consists of the catalytic domain (s1), a polycystic kidney disease domain
(PKD, s2), and two collagen-binding domains (CBD, s3a and s3b). Mean-
while, ColH collagenase consists of s1, two PKDs (s2a and s2b), and one
CBD (s3). The PKD domain was first identified in the Polycystic Kidney Dis-
ease protein, polycystin-1. Its role in collagenolysis is unknown. The high
resolution crystal structures of the calcium bound (holo) s2b (1.4 A˚ resolu-
tion, Rfactor = 17.4%, Rfree = 19.3%) and two crystal forms of the calcium
free (apo) s2 (Form I 1.6 A˚ resolution, Rfactor = 18.9%, Rfree = 21.3%.
Form II 1.4 A˚ resolution, Rfactor = 18.7%, Rfree = 23.0%) have been
determined. PKD adopts an immunoglobulin-like cylindrical fold. Two
beta-strands are shortened by a tight turn (FGDG) unique to PKD. The s2b
chelates to a calcium ion in pentagonal bipyramidal coordination (one water,
main-chain carbonyl, side-chains of asparagine and three aspartates). The
structure based sequence alignment reveals that architecturally important
hydrophobic residues found in the core, and calcium-chelating residues are
conserved only in bacterial PKD. The calcium-chelating residues are notfound in archaea and animal PKD. The molecular shape of s2a-s2b-s3 calcu-
lated from small angle X-ray scattering (SAXS) data resembles a crowbar.
The tandem PKD domains occupy the 86.4 A˚ handle of the ‘‘crowbar’’.
The tandem PKD segment is likely rigid only when bound to calcium and
may collapse in the absence. The s2a-s2b-s3 segment possibly pries itself be-
tween collagen fibrils. It is also possible that collagen is sandwiched between
s2b-s3.
1271-Pos Board B41
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Rebecca Goldstein, Jiongjia Cheng, Mary Roberts.
Boston College, Chestnut Hill, MA, USA.
Staphylococcus aureus secretes a phosphatidylinositol-specific phospholipase
C (PIPLC) that contributes to bacterial virulence. We have determined the
crystal structure of this enzyme at pH 4.6 and pH 7.5. When crystallized under
slightly basic conditions (pH 7.5), the S. aureus PIPLC (SaPI-PLC) structure
closely follows the conformation of other PI-PLCs. However, when crystal-
lized under acidic conditions (pH 4.6), a large section of mobile loop at the
ab-barrel rim in the vicinity of the active site shows ~10 A˚ shift from the po-
sition of this loop in all other published PI-PLC structures. The cause of this
loop shift under acidic conditions is the result of a titratable intramolecular p-
cation interaction between His258 and Phe249. A structure of the mutant pro-
tein H258Y crystallized at pH 4.6 does not exhibit this interaction, and the
mobile loop remains in the open position. The p-cation latched mobile
loop, when in the closed position, can restrict substrate access to the active
site. The pH profile for enzyme activity exhibits a maximum at pH 6.5 with
steep decreases at pH 6 and 7. Studies of the enzyme binding to vesicles in-
dicate the Kd is lower at acidic pH values (consistent with electrostatic inter-
actions dominating binding) and increases dramatically above pH 7. Thus,
rather than affect bulk binding of the protein to target vesicles, this titratable
p-histidine cation interaction must affect access of the substrate in the active
site.
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The Ab42 peptide associated with Alzheimer’s Disease is derived by proteol-
ysis of the amyloid precursor protein (APP). Within the Ab sequence are three
consecutive GxxxG motifs that mediate both helix interactions in APP and
b-sheet interactions in Ab42. The GxxxG motif was originally shown to medi-
ate helix interactions in the TM domain of glycophorin A. More recent studies
have shown that amyloid fibrils formed from glycophorin A fragments contain
parallel and in-register b-strands, as in Ab42, and that the b-sheets within
glycophorin A fibrils are stabilized by a central ridge of methionine residues
packing against grooves created by glycines of the GxxxG motif. Strikingly,
sequence analysis of the human prion protein reveals three consecutive GxxxG
motifs in an amyloidogenic region from 118-135.
In this investigation, 13C solid-state NMR spectroscopy is used to probe the
structure of amyloid fibrils formed from the human PrP(118-135) peptide.
We show that fibrils of PrP(118-135) have a parallel and in-register architecture
where b-sheet-to-b-sheet packing is facilitated by side chain interactions in-
volving Met129 packing against either Gly127 or Gly131 of a GxxxG motif.
Peptide inhibitors, designed with a GxFxGxF framework and previously shown
to block Ab fibril formation, were tested on PrP(118-135) and found to inhibit
fibril formation and block inter-sheet packing. The data show both Ab and
PrP(118-135) form similar fibrils and can be inhibited using the same generi-
cally designed peptide.
Interestingly, both Ab and PrP form b-sheet rich aggregates that cause neuro-
degenerative disease. Lauren et al. (Nature 457, 1128) proposed Ab42 might
exert toxicity on neuronal cells by binding to human prion protein at residues
95-110. We have carried out FTIR and NMR studies to characterize interac-
tions between PrP (95-136) and Ab42, and the possible role of GxxxG
sequences.
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